GGrantIndex
← Leaderboards

Lee W Jones

Duke University

$15,873,984
Attributed
$19,083,931
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,083,931 · 10

By mechanism

R01$17,470,285 · 6
R21$1,460,117 · 3
R03$153,529 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Exercise

Research focus

ExerciseGrantDiagnosisRandomized TrialCancer PatientTrainingMalignant NeoplasmsMalignant Breast NeoplasmPatient Outcomes AssessmentsSedentaryProspectiveFutureAerobicWomanDesignToxic EffectFatigueQuality Of LifeSafetyBaseStagingCancer TherapyRelative (Related Person)Laboratories

Grant awards (48)

Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer$839,781
R01 · FY2025 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$693,662
R01 · FY2025 · CA · contact PI
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:$658,881
R01 · FY2024 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$624,661
R01 · FY2024 · CA · contact PI
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:$679,692
R01 · FY2023 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$644,390
R01 · FY2023 · CA · contact PI
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:$715,452
R01 · FY2022 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$644,389
R01 · FY2022 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$193,799
R01 · FY2021 · CA · contact PI
Exercise as Interception Therapy in Primary High Risk Cancer$725,188
R01 · FY2020 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$568,710
R01 · FY2019 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$521,021
R01 · FY2019 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$648,503
R01 · FY2018 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$515,269
R01 · FY2018 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$909,181
R01 · FY2017 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$508,472
R01 · FY2017 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$416,095
R01 · FY2017 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$175,891
R01 · FY2015 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$156,197
R01 · FY2015 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$116,187
R01 · FY2015 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$547,430
R01 · FY2014 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$417,970
R01 · FY2014 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$43,530
R01 · FY2014 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$788,336
R01 · FY2013 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$419,640
R01 · FY2013 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$362,645
R01 · FY2013 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$231,630
R01 · FY2013 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$45,900
R01 · FY2013 · CA · contact PI
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'$45,183
R01 · FY2013 · CA · contact PI
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial$627,768
R01 · FY2012 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$400,379
R01 · FY2012 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$172,950
R01 · FY2012 · CA · contact PI
Phase II Trial of Aerobic Training in Metastatic Breast Cancer$144,060
R21 · FY2012 · CA · contact PI
Phase II Trial of Aerobic Training in Metastatic Breast Cancer$21,556
R21 · FY2012 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$520,574
R01 · FY2011 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$404,458
R01 · FY2011 · CA · contact PI
Phase II Trial of Aerobic Training in Metastatic Breast Cancer$165,616
R21 · FY2011 · CA · contact PI
Exercise Training, Erectile Dysfunction, and Prostate Cancer$160,838
R21 · FY2011 · CA · contact PI
Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer$600,068
R01 · FY2010 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$417,275
R01 · FY2010 · CA · contact PI
Phase II Trial of Aerobic Training in Metastatic Breast Cancer$204,885
R21 · FY2010 · CA · contact PI
Exercise Training, Erectile Dysfunction, and Prostate Cancer$185,247
R21 · FY2010 · CA · contact PI
Phase III Trial of Exercise Training in Postsurgical Lung Cancer$469,128
R01 · FY2009 · CA · contact PI
Using Message Framing to Promote Physical Activity in Colorectal Cancer Survivors$210,600
R21 · FY2009 · CA · contact PI
Exercise Training, Erectile Dysfunction, and Prostate Cancer$156,715
R21 · FY2009 · CA · contact PI
Using Message Framing to Promote Physical Activity in Colorectal Cancer Survivors$210,600
R21 · FY2008 · CA · contact PI
Changes in Functional Status Across Therapy for Primary Glioma$75,738
R03 · FY2007 · CA · contact PI
Changes in Functional Status Across Therapy for Primary Glioma$77,791
R03 · FY2006 · CA · contact PI